Literature DB >> 18449940

Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience.

Christine Maheu1, Sally Thorne.   

Abstract

We examined the experience of 21 women diagnosed with breast or ovarian cancer who received inconclusive BRCA1/2 genetic test results. Although these women received similar information on the technical meaning of an inconclusive result, their interpretations of personal risk for a probable, inherited cancer mutation differed. Their interpretations ranged from confidence that they probably carried an undetected gene mutation to believing that their cancer had no genetic basis. Women drew from their personal experience with genetic testing and from distinctive perceptions and beliefs in attempting to understand their test results; they variously drew upon such evidence as observations of similarities and differences within familial breast/ovarian cancer patterns to explain their ultimate conclusions as to their own genetic status. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18449940     DOI: 10.1002/nur.20286

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  11 in total

Review 1.  Incidental findings from clinical genome-wide sequencing: a review.

Authors:  Z Lohn; S Adam; P H Birch; J M Friedman
Journal:  J Genet Couns       Date:  2013-05-26       Impact factor: 2.537

2.  Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives.

Authors:  Audrey Ardern-Jones; Regina Kenen; Elly Lynch; Rebecca Doherty; Rosalind Eeles
Journal:  Hered Cancer Clin Pract       Date:  2010-01-12       Impact factor: 2.857

3.  Ability of Patients to Distinguish Among Cardiac Genomic Variant Subclassifications.

Authors:  Lydia D Hellwig; Barbara B Biesecker; Katie L Lewis; Leslie G Biesecker; Cynthia A James; William M P Klein
Journal:  Circ Genom Precis Med       Date:  2018-06

4.  Experiences and interpretations of BRCA1/2 testing among women affected by breast or ovarian cancer who received a negative result.

Authors:  Lesley Stafford; Alison Flehr; Fiona Judd; Geoffrey J Lindeman; Penny Gibson; Angela Komiti; G Bruce Mann; Maira Kentwell
Journal:  J Community Genet       Date:  2019-03-27

5.  "Grasping the grey": patient understanding and interpretation of an intermediate allele predictive test result for Huntington disease.

Authors:  A Semaka; L G Balneaves; M R Hayden
Journal:  J Genet Couns       Date:  2012-08-18       Impact factor: 2.537

6.  Parents' Experience with Pediatric Microarray: Transferrable Lessons in the Era of Genomic Counseling.

Authors:  R Z Hayeems; R Babul-Hirji; N Hoang; R Weksberg; C Shuman
Journal:  J Genet Couns       Date:  2015-08-12       Impact factor: 2.537

7.  "Nothing is absolute in life": understanding uncertainty in the context of psychiatric genetic counseling from the perspective of those with serious mental illness.

Authors:  Catriona Hippman; Zoe Lohn; Andrea Ringrose; Angela Inglis; Joanna Cheek; Jehannine C Austin
Journal:  J Genet Couns       Date:  2013-04-21       Impact factor: 2.537

8.  Developing qualitative methods - or "same old wine in a new bottle".

Authors:  Carina Berterö
Journal:  Int J Qual Stud Health Well-being       Date:  2015-05-13

Review 9.  Communication about genetic testing with breast and ovarian cancer patients: a scoping review.

Authors:  Chris Jacobs; Christine Patch; Susan Michie
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

10.  "What does it mean?": uncertainties in understanding results of chromosomal microarray testing.

Authors:  Marian Reiff; Barbara A Bernhardt; Surabhi Mulchandani; Danielle Soucier; Diana Cornell; Reed E Pyeritz; Nancy B Spinner
Journal:  Genet Med       Date:  2012-01-05       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.